Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2017-06-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Ingesting a Tomato Pomace Extract on Platelet Aggregation
NCT02986165
Identifying the Anti-Blood-Clotting Compounds in Garlic
NCT00200785
Kinetic of Melatonin Subsequent to the Consumption of Melatonin-rich Food Supplements
NCT04574141
Investigations on the Effect of Kale on the Lipid Status
NCT03545555
Kinetic of Compounds of a Melatonin-based Formulation in Healthy Subjects
NCT05419466
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study wishes to evaluate coagulation abnormalities using viscoelastic point-of-care coagulation monitoring in this population. This test is readily available in large hospitals and academic settings and is increasingly being used in perioperative medicine. It provides information on coagulation and thrombolysis with minimal delay when compared to other laboratory-based coagulation tests.
The dietary supplements which will be evaluated in this study are ginger, garlic, gingko biloba and ginseng. These four herbal supplements were identified as the most commonly used substances known to modulate the coagulation system. These herbal supplements will be investigated within their maximum daily allowance dosages.
A five-armed placebo-controlled study will be undertaken and study subjects will be recruited on a volunteer basis. Subjects will be divided into five groups and each group will receive one of the four dietary supplements and the fifth group placebo, for a two week period. Rotational thromboelastometry (ROTEM) studies will be performed on blood samples obtained from each participant at baseline and at the end of the treatment period to identify coagulation abnormalities. Most of these herbal medicines have been identified to affect platelet function and this study will specifically look at platelet function determined by maximum clot firmness (MCF) in the ROTEM analysis.
Viscoelastic point-of-care coagulation monitoring in patients using herbal medicines and dietary supplements will aid decision making regarding cause of perioperative haemorrhage and need for specific blood products. It will therefore assist with goal-directed management of perioperative haemorrhage. It will also aid the anaesthetist wishing to employ a regional anaesthetic technique in this patient group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ginger
Ginger ( Zingiber officinale) 4 grams po dly for 14 days
Ginger
Ginger dosage at daily recommended allowance
Garlic
Garlic (Allium sativum) 4-12 mg alliin po dly for 14 days
Garlic
Garlic dosage at daily recommended allowance
Ginkgo Biloba
Ginkgo Biloba 40mg po tds for 14 days
Ginkgo Biloba
Ginkgo Biloba dosage at daily recommended allowance
Ginseng
Ginseng 400mg po dly for 14 days
Ginseng
Ginseng dosage at daily recommended allowance
Placebo
Placebo po dly for 14 days
Placebo
Daily dosage strategy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ginger
Ginger dosage at daily recommended allowance
Garlic
Garlic dosage at daily recommended allowance
Ginkgo Biloba
Ginkgo Biloba dosage at daily recommended allowance
Ginseng
Ginseng dosage at daily recommended allowance
Placebo
Daily dosage strategy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Both males and females
3. Healthy volunteers
4. Smokers and Non-smokers
5. Staff frequenting the theatre complex at Steve Biko Academic Hospital
Exclusion Criteria
3. Current excessive alcohol intake - more than 14 units a week in woman and more than 21 units a week in men.
4. Pregnant or lactating mothers.
5. Possible planned surgery during the study period
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pretoria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jayde Wyngaard
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jayde V Wyngaard, MBCHB
Role: PRINCIPAL_INVESTIGATOR
University of Pretoria
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMed Anaesthesiology -15402364
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.